Position in ANGO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,008,470
+$250,919 QoQ
Shares Held
154,379
-0.1% QoQ
Ownership
0.374%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 162 holders
Holding Since
Dec 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANGO Over Time
Shares Held
Position Value (USD)
Position in Medical Instruments & Supplies
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $492,138,070 across 17 Medical Instruments & Supplies names. ANGO ranks #6 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ISRG |
Intuitive Surgical Inc
|
925,814 | $368,177,711 | |
| 2 | XRAY |
DENTSPLY SIRONA Inc.
|
8,269,867 | $87,743,288 | |
| 3 | BDX |
Becton Dickinson & Co
|
129,021 | $19,524,747 | |
| 4 | LMAT |
Lemaitre Vascular Inc
|
61,333 | $5,885,514 | |
| 5 | NVST |
Envista Holdings Corp
|
79,828 | $2,103,467 | |
| 6 | ANGO |
Angiodynamics Inc
This page
|
154,379 | $2,008,470 | |
| 7 | MDLN |
Medline Inc.
|
38,874 | $1,533,190 | |
| 8 | SOLV |
Solventum Corp
|
17,452 | $1,346,421 |
All Filings in ANGO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,008,470 | 154,379 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,757,551 | 154,578 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $138,967 | 10,823 | Shares | Sole | 2026-02-17 | |
| 2023-09-30 | $41,864 | 5,727 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $55,329 | 5,351 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $67,954 | 4,935 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $100,970 | 4,935 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $127,361 | 6,582 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $109,078 | 5,064 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $248,136 | 8,997 | Shares | Sole | 2022-02-09 | |
| No filing history on record for this holder in this stock. | ||||||